⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13305742 | 0.74 | — | — | |
| SCHEMBL452524 | 0.61 | — | — | |
| SCHEMBL121542 | 0.61 | — | — | |
| SCHEMBL7788320 | 0.60 | — | — | |
| SCHEMBL8285794 | 0.60 | — | — | |
| SCHEMBL1304127 | 0.60 | — | — | |
| SCHEMBL18778711 | 0.57 | — | — | |
| SCHEMBL10523922 | 0.56 | — | — | |
| SCHEMBL256978 | 0.56 | — | — | |
| SCHEMBL3282168 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1272474-A1 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | Bayer Aktiengesellschaft (DE) | 2003-01-08 | — | — | EP | claimed |
| WO-2001064652-A9 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | BAYER AG (DE) | 2002-07-04 | — | — | WO | claimed |
| WO-2001064652-A1 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-07 | — | — | WO | claimed |
| EP-4129996-A1 | NOVEL AMINOPYRIMIDINE EGFR INHIBITOR | QILU PHARMACEUTICAL CO., LTD. (CN) | 2023-02-08 | — | — | EP | disclosed |
| EP-1272474-A1 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | Bayer Aktiengesellschaft (DE) | 2003-01-08 | — | — | EP | disclosed |
| EP-1272474-A1 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | Bayer Aktiengesellschaft (DE) | 2003-01-08 | — | — | EP | disclosed |
| WO-2001064652-A9 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | BAYER AG (DE) | 2002-07-04 | — | — | WO | disclosed |
| WO-2001064652-A9 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | BAYER AG (DE) | 2002-07-04 | — | — | WO | disclosed |
| WO-2001064652-A1 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-07 | — | — | WO | disclosed |
| WO-2001064652-A1 | SUBSTITUTED 5-METHYLDIHYDROPYRIDAZINONES AND THEIR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF ANEMIAS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-07 | — | — | WO | disclosed |